New heat-activated gel could boost liver cancer treatment

NCT ID NCT07356531

First seen Jan 26, 2026 · Last updated May 22, 2026 · Updated 16 times

Summary

This study tests a new gel that hardens at body temperature to block blood flow to liver tumors during chemoembolization. About 216 adults with liver cancer will be randomly assigned to receive either the new gel or standard gelatin sponge particles alongside chemotherapy. The goal is to see if the new gel better controls tumor growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Cancer Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, 530012, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Anhui Provincial Hospital

    RECRUITING

    Hefei, Anhui, 230002, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Anyang Tumor Hospital

    RECRUITING

    Anyang, Henan, 455001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • First Affiliated Hospital of Gannan Medical University

    RECRUITING

    Ganzhou, Jiangxi, 341099, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, 450000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Jilin Guowen Hospital

    RECRUITING

    Gongzhuling, Jilin, 130028, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Lishui Central Hospital

    RECRUITING

    Lishui, Zhejiang, 323020, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Peking University First Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shanxi Bethune Hospital

    RECRUITING

    Taiyuan, Shanxi, '030032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Affiliated Cancer Hospital of Guizhou Medical University

    RECRUITING

    Guiyang, Guizhou, 550008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Henan University of Science & Technology

    RECRUITING

    Luoyang, Henan, 471023, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Wenzhou Medical University

    RECRUITING

    Wenzhou, Zhejiang, 325000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Fourth Hospital of Hebei Medical University (Hebei Provincial Cancer Hospital)

    RECRUITING

    Shijiazhuang, Hebei, '050010, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, 330008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Yichang Central People's Hospital

    RECRUITING

    Yichang, Hubei, 443008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.